New York Blood Center Enterprises Celebrates the Expansion of Cell & Gene Therapy GMP Manufacturing Capabilities at the Grand Opening of Louisville, Kentucky Site NEW YORK and LOUISVILLE, Ky., May 23, 2024 (GLOBE NEWSWIRE) -- Comprehensive Cell Solutions (CCS), a business unit of New York Blood Center Enterprises (NYBCe), announced today the grand opening of...

New York Blood Center Enterprises Makes Investment to Advance Next-Generation Red Blood Cell Research BOSTON, Dec. 07, 2023 (GLOBE NEWSWIRE) -- New York Blood Center Enterprises (NYBCe) announced today that its venture fund, NYBC Ventures, has invested in Functional Fluidics to advance research in...

New York Blood Center Enterprises Grants Exclusive License to Big Eye Diagnostics for Diagnostic Biomarkers in River Blindness NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- New York Blood Center Enterprises (NYBCe) announced today it granted an exclusive commercial license to Big Eye Diagnostics for the rights to develop a...